弥漫性肝窦状血管肉瘤并发急性上消化道出血1例并文献复习

doi:10.3969/j.issn.1672-5069.2024.02.039

Abstract

Huang Die, Lin Xuyong, Li Yiling, et al.. Diffuse sinusoidal-type hepatic angiosarcoma complicated by acute upper gastrointestinal bleeding: a case report and literature review[J]. Journal of Practical Hepatology, 2024, 27(2): 314-316.

References

[1] Bhati CS, Bhatt AN, Starkey G, et al. Acute liver failure due to primary angiosarcoma: a case report and review of literature. World J Surg Oncol, 2008,6:104.
[2] Kumar A, Sharma B, Samant H. Liver angiosarcoma//Treasure Island (FL),2023:125-127.
[3] Singh G, Mills C, Asadi K, et al. Hepatic angiosarcoma as a cause of acute liver failure. BMJ Case Rep, 2012,2012:bcr2012006417.
[4] Lazăr DC, Avram MF, Romoan I, et al. Malignant hepatic vascular tumors in adults: Characteristics, diagnostic difficulties and current management.World J Clin Oncol, 2019,10(3):110-135.
[5] Yasir S, Torbenson MS. Angiosarcoma of the liver: Clinicopathologic features and morphologic patterns. Am J Surg Pathol, 2019,43(5):581-590.
[6] Rosen EA, Vallurupalli M, Choy E, et al. Management of disseminated intravascular coagulation in a patient with hepatic angiosarcoma: A case report. Medicine (Baltimore), 2018,97(47):e13321.
[7] Ito Z, Kajihara M, Kobayashi Y, et al. Hepatic angiosarcoma associated with esophageal variceal hemorrhage. Case Rep Gastroenterol, 2016,10(2): 440 -445.
[8] Enweluzo C, Chaudry D, Philip JK, et al. Hepatic angiosarcoma: An unusual case of intractable gastrointestinal bleeding. Gastroenterol Res, 2013,6(2):74-76.
[9] Zheng YW, Zhang XW, Zhang JL, et al. Primary hepatic angiosarcoma and potential treatment options. J Gastroenterol Hepatol, 2014,29 (5):906-911.
[10] Yi LL, Zhang JX, Zhou SG, et al. CT and MRI studies of hepatic angiosarcoma. Clin Radiol, 2019,74(5):406,e1-406,e8.
[11] Gaballah AH, Jensen CT, Palmquist S, et al. Angiosarcoma: clinical and imaging features from head to toe. Br J Radiol,2017,90 (1075):20170039.
[12] 张伟,王兰荣,薛鹏等.原发性肝血管肉瘤的CT和MRI表现. 临床放射学杂志,2014,33(5): 734-738.
[13] Zen Y, Sofue K. Sinusoidal-type angiosarcoma of the liver: Imaging features and potential diagnostic utility of p53 immunostaining. Am J Surg Pathol, 2019,43(12):1728-1731.
[14] Vij M, Patil V, Hakeem A, et al. Sinusoidal hepatic angiosarcoma on a background of non-cirrhotic portal hypertension and nodular regenerative hyperplasia masquerading as acute on chronic liver failure. J Gastrointest Cancer, 2021,52(2):766-770.
[15] Pickhardt PJ, Kitchin D, Lubner MG, et al. Primary hepatic angiosarcoma: multi-institutional comprehensive cancer centre review of multiphasic CT and MR imaging in 35 patients. Eur Radiol,2015,25 (2):315-322.
[16] Ogawa M, Ae R, Sasahara T. Primary hepatic angiosarcoma: A case report with 10-year patient medical data. Case Rep Oncol, 2017,10(3):851-856.
[17] Zeng D, Cheng J, Gong Z, et al. A pooled analysis of primary hepatic angiosarcoma. Jpn J Clin Oncol, 2020,50(5):556-567.
[18] Penel N, Bui BN, Bay JO, et al. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. J Clin Oncol, 2008,26(32):5269-5274.
[19] Qiao Y, Yang J, Liu L, et al. Successful treatment with pazopanib plus PD-1 inhibitor and RAK cells for advanced primary hepatic angiosarcoma: a case report. BMC Cancer, 2018,18(1):212.
[20] Miettinen M, Rikala MS, Rys J, et al. Vascular endothelial growth factor receptor 2 as a marker for malignant vascular tumors and mesothelioma: an immunohistochemical study of 262 vascular endothelial and 1640 nonvascular tumors. Am J Surg Pathol,2012,36 (4):629-639.
[21] Jiang L, Xie L, Li G, et al. Clinical characteristics and surgical treatments of primary hepatic angiosarcoma. BMC Gastroenterol, 2021,21(1):156.

Diffuse sinusoidal-type hepatic angiosarcoma complicated by acute upper gastrointestinal bleeding: a case report and literature review

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 14

Recommended Articles

Metrics

Comments

[1]	Zhang Lili, Zhang Chun, Wang Yitong, et al.. Clinical characteristics of systemic sclerosis complicated with primary biliary cholangitis and portal hypertension: Analysis of 12 cases [J]. Journal of Practical Hepatology, 2023, 26(2): 230-233.
[2]	Shen Yan, Chen Lin. Endoscopic treatment and long-term management of patients with esophagogastric variceal bleeding [J]. Journal of Practical Hepatology, 2023, 26(1): 8-10.
[3]	Zhuge Yuzheng, Wang Xuan. Hepatic sinusoidal obstruction syndrome associated with pyrrolizidine alkaloids [J]. Journal of Practical Hepatology, 2021, 24(5): 617-620.
[4]	Chen Shan, Zhuang Huashuai, Xing Yixi, et al. Preventive application of meropenem in patients with liver cirrhosis complicated by upper gastrointestinal bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 704-707.
[5]	Liu Xiaoli, Fang Ling, Zhu Minghua, et al. Comparative analysis of meropenem and ceftriaxone in prevention of nosocomial infections in cirrhotic patients complicated by upper gastrointestinal bleeding [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 593-596.
[6]	Wang Ming, Ni Zhi. Clinical efficacy of octreotide in the treatment of 177 patients with liver cirrhosis complicated by upper gastrointestinal bleeding [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(1): 114-115.
[7]	Chen Jianhui, Ma Lin.. Risk factors for gastric bleeding in patients with hepatitis B-induced liver cirrhosis and portal hypertensive gastropathy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(4): 431-434.
[8]	Yang Xingping, Chen Heping. Prophylactic application of ceftriaxone sodium in treatment of patients with liver cirrhosis complicated by upper gastrointestinal bleeding [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(3): 362-363.
[9]	Pang Guohong, Li Lingjun, Yang Rulei. Changes of hepatic vein pressure gradients in patients with liver cirrhosis and upper gastrointestinal bleeding receiving terlipressin combined with esomeprazole [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(3): 364-365.
[10]	Yang Hui, Zhou Xiaoyan, Zhou Yanfen, et al. Octreotide and Gexiazhuyutang,a herbal medicine compounds,in treatment of patients with liver cirrhosis complicated by upper gastrointestinal bleeding [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(4): 459-462.
[11]	Chen Chun, Wu Siguo, Yang ZhiJuan. Prognostic factors in patients with liver cirrhosis complicated by upper gastrointestinal bleeding [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(3): 300-301.
[12]	Zhang Junfei, Liu Bo, Chen Congxin. Increased challenge in traditional Chinese medicine containing pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(4): 445-455.
[13]	Sun Wenjing,Chen Dongfeng.. Diagnosis and treatment strategy of patients with liver failure and gastrointestinal bleeding [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(2): 202-205.
[14]	Wang Yong, Ding Tilong, Ma Yong, et al.. The pathological changes of hepatic sinusoids in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2012, 15(4): 309-311.